{
 "name": "科懋",
 "slug": "tw-6496",
 "aliases": [
  "科懋生物科技股份有限公司",
  "Excelsior",
  "6496"
 ],
 "ticker": "6496",
 "industry": "生技醫療業",
 "website": "http://www.excelsiorgroup.com.tw",
 "summary": "科懋（6496）是上櫃的生技醫療類股公司，1988 年成立，2016 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "科懋生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "Excelsior",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2016-01-07",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "1988-07-21",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "陳澤民",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "陳澤民",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 472902200,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.excelsiorgroup.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 76368,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-當月營收；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 7.29,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-去年同月增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 9.95,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：累計營業收入-前期比較增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "管線：EX028（脂妙清／Omacor；omega-3-acid ethyl esters 90）",
   "value": "高三酸甘油酯症｜已上市｜台灣",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "法說第15頁載2016年7月上市；藥證衛部藥製字第059019號。"
  },
  {
   "claim": "管線：EX039（sodium benzoate／安息香酸鈉）",
   "value": "輕度阿茲海默症｜Phase II收案中｜台灣",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "NCT05413655。產品代號亦寫EX-039；區域由該NCT登錄之台灣試驗中心交叉核對。"
  },
  {
   "claim": "管線：EX042（TGF-beta抑制劑）",
   "value": "肺動脈高壓｜細胞試驗及動物模式研究｜地區未揭露",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "未把細胞或動物試驗視為人體臨床；簡報未揭露特定分子學名及地區。"
  },
  {
   "claim": "管線：EX036（學名未揭露）",
   "value": "法布瑞氏症｜Drug Discovery（管線圖標示）｜地區未揭露",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "依第62頁圖表階段；未揭露地區、NCT或試驗進行／完成狀態，未自行推定收案或結果。"
  },
  {
   "claim": "管線：EX043（IGFBP3抑制劑）",
   "value": "促進傷口癒合｜Drug Discovery（管線圖標示）｜地區未揭露",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "依第62頁圖表階段；未揭露地區、NCT或試驗進行／完成狀態，未自行推定收案或結果。"
  },
  {
   "claim": "管線：EX044（罕見疾病專用藥）",
   "value": "威爾森氏症｜管線圖列至Phase III（試驗執行狀態未揭露）｜地區未揭露",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "依第62頁圖表階段；未揭露地區、NCT或試驗進行／完成狀態，未自行推定收案或結果。"
  },
  {
   "claim": "管線：EX054（基因治療）",
   "value": "有機酸血症｜Preclinical（管線圖標示）｜地區未揭露",
   "unit": "",
   "as_of": "2025-12-16",
   "source": "https://www.excelsiorgroup.com.tw/upload/5103/2025121910250120251216M001.pdf",
   "note": "依第62頁圖表階段；未揭露地區、NCT或試驗進行／完成狀態，未自行推定收案或結果。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6496.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}